AP Health Writer WASHINGTON (AP) — Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos Therapeutics announced the FDA’s decision on Friday.
WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental health conditions.
The FDA's decision Aug. 11 could mark a major shift in PTSD treatment for veterans. MDMA-AT, more commonly known as ecstasy or molly, shows promising results in therapy.
By Deidre McPhillips, CNN (CNN) — The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news release from drug sponsor Lykos Therapeutics.
US health regulators on Friday denied an application for treating post-traumatic stress disorder (PTSD) with the drug MDMA, commonly known as ecstasy, saying more investigation needed to be done.
A US company seeking to use MDMA capsules to treat post-traumatic stress disorder has said federal regulators rejected the bid. Lykos Therapeutics said the FDA requested an additional Phase 3 trial to gather more data.
The FDA denied approval for the use of MDMA, or ecstacy, to enhance talk therapy for PTSD patients. PTSD has not had a new treatment for nearly 25 years.
A US company seeking to use MDMA capsules to treat post-traumatic stress disorder has said federal regulators rejected the bid. Lykos Therapeutics said the FDA requested an additional Phase 3 trial to gather more data.
WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a
WASHINGTON -- Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental health conditions.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
FDA rejects MDMA as psychedelic-based treatment for mental health, PTSD | Since Then
